<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK299584" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK299584/" /><meta name="ncbi_pagename" content="Prolidase Deficiency - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Prolidase Deficiency - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Prolidase Deficiency" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/06/25" /><meta name="citation_author" content="Carlos Ferreira" /><meta name="citation_author" content="Heng Wang" /><meta name="citation_pmid" content="26110198" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK299584/" /><meta name="citation_keywords" content="Xaa-Pro dipeptidase" /><meta name="citation_keywords" content="PEPD" /><meta name="citation_keywords" content="Prolidase Deficiency" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Prolidase Deficiency" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Carlos Ferreira" /><meta name="DC.Contributor" content="Heng Wang" /><meta name="DC.Date" content="2015/06/25" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK299584/" /><meta name="description" content="Prolidase deficiency is characterized by skin lesions (typically severe, chronic, recalcitrant, and painful skin ulcers of the lower extremities and telangiectasias of the face and hands), recurrent infections (particularly of the skin and respiratory tract), dysmorphic facial features, variable intellectual disability, and hepatomegaly with elevated liver enzymes and splenomegaly. Anemia, thrombocytopenia, hypergammaglobulinemia, and hypocomplementemia are common. An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described." /><meta name="og:title" content="Prolidase Deficiency" /><meta name="og:type" content="book" /><meta name="og:description" content="Prolidase deficiency is characterized by skin lesions (typically severe, chronic, recalcitrant, and painful skin ulcers of the lower extremities and telangiectasias of the face and hands), recurrent infections (particularly of the skin and respiratory tract), dysmorphic facial features, variable intellectual disability, and hepatomegaly with elevated liver enzymes and splenomegaly. Anemia, thrombocytopenia, hypergammaglobulinemia, and hypocomplementemia are common. An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK299584/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/prolidase-def/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK299584/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88CB67DFC8F1E10000000002930133.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK299584_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK299584_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ppr-dysp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pomc-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK299584_"><span class="title" itemprop="name">Prolidase Deficiency</span></h1><p class="contrib-group"><span itemprop="author">Carlos Ferreira</span>, MD and <span itemprop="author">Heng Wang</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK299584_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK299584_ai__"><div class="contrib half_rhythm"><span itemprop="author">Carlos Ferreira</span>, MD<div class="affiliation small">National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin@arierref.solrac" class="oemail">vog.hin@arierref.solrac</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Heng Wang</span>, MD, PhD<div class="affiliation small">DDC Clinic for Special Needs Children<br />Middlefield, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cinilccdd@gnaw" class="oemail">gro.cinilccdd@gnaw</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 25, 2015</span>.</p><p><em>Estimated reading time: 25 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="prolidase-def.Summary" itemprop="description"><h2 id="_prolidase-def_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Prolidase deficiency is characterized by skin lesions (typically severe, chronic, recalcitrant, and painful skin ulcers of the lower extremities and telangiectasias of the face and hands), recurrent infections (particularly of the skin and respiratory tract), <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, variable intellectual disability, and hepatomegaly with elevated liver enzymes and splenomegaly. Anemia, thrombocytopenia, hypergammaglobulinemia, and hypocomplementemia are common. An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of prolidase deficiency is established by detection of either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PEPD</i> pathogenic variants or reduced prolidase enzyme activity in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who has characteristic clinical findings and imidodipeptiduria.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> No curative treatment is available. Supportive treatment of skin, lung, and immunologic manifestations has been efficacious in some (but not in all) patients. Caution is warranted in the treatment of infections, which can be fulminant and fatal. Developmental and educational interventions as needed to address motor and cognitive delays.</p><p><i>Prevention of secondary complications:</i> Those who have undergone splenectomy should be appropriately immunized and treated promptly with antibiotics at the first sign of infection. Antibiotic prophylaxis should also be considered in the appropriate setting.</p><p><i>Surveillance:</i> In the absence of formal surveillance guidelines, the authors recommend annual: skin examination for evidence of malignant transformation in persons with chronic recalcitrant skin ulcers, complete blood count, liver function tests, and abdominal ultrasound examination to assess the size of the liver and spleen. Follow up as recommended by a pulmonologist and immunologist. Follow-up assessments of motor and cognitive development as recommended for educational planning.</p><p><i>Agents/circumstances to avoid:</i> In those with splenomegaly: avoid contact sports given the increased risk for splenic rupture.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Prolidase deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>PEPD</i> pathogenic variants in the family have been identified.</p></div></div><div id="prolidase-def.Diagnosis"><h2 id="_prolidase-def_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria or testing algorithms for prolidase deficiency have been published.</p><div id="prolidase-def.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Prolidase deficiency <b>should be suspected</b> in individuals with the following clinical, laboratory, and biochemical findings.</p><p><b>Clinical</b></p><ul><li class="half_rhythm"><div>Skin lesions, typically lower extremity ulcers. Other lesions such as telangiectasias of the face and hands are also common [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>, <a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al 2011</a>].</div></li><li class="half_rhythm"><div>Recurrent infections, particularly of the skin and respiratory tract [<a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al 1994</a>]</div></li><li class="half_rhythm"><div>Chronic lung disease with digital clubbing and a cystic fibrosis-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#prolidase-def.REF.luder.2007.656">Luder et al 2007</a>]</div></li><li class="half_rhythm"><div>Dysmorphic facial features, including widely spaced eyes, proptosis, depressed nasal bridge, prognathism, thin vermilion of the upper lip, and low anterior and posterior hairline [<a class="bk_pop" href="#prolidase-def.REF.goodman.1968.152">Goodman et al 1968</a>, <a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al 2011</a>]</div></li><li class="half_rhythm"><div>Developmental delay of variable degree [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>, <a class="bk_pop" href="#prolidase-def.REF.lupi.2008.739">Lupi et al 2008</a>, <a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al 2015</a>]</div></li><li class="half_rhythm"><div>Splenomegaly [<a class="bk_pop" href="#prolidase-def.REF.nasser.2015.169">Nasser et al 2015</a>]</div></li><li class="half_rhythm"><div>Systemic lupus erythematosus-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.klar.2010.727">Klar et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>]</div></li></ul><p><b>Laboratory.</b> Frequent, although not universal, laboratory findings include the following:</p><ul><li class="half_rhythm"><div>Anemia, usually mild (hemoglobin &#x0003e;10 g/dL), but occasionally below that value [<a class="bk_pop" href="#prolidase-def.REF.powell.1974.505">Powell et al 1974</a>, <a class="bk_pop" href="#prolidase-def.REF.moulonguet.1989.792">Moulonguet et al 1989</a>, <a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al 1994</a>]</div></li><li class="half_rhythm"><div>Thrombocytopenia, usually mild (&#x0003e;100,000 platelets per &#x003bc;L), although rarely it can be lower [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>]</div></li><li class="half_rhythm"><div>Elevated liver enzymes, with elevation of aspartate aminotransferase in the 100s [<a class="bk_pop" href="#prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</a>]</div></li><li class="half_rhythm"><div>Hypergammaglobulinemia, mainly elevation of IgG and IgA, although occasionally also elevation of IgM. Reference ranges for immunoglobulins are age dependent, but upper limits of normal at any age are: IgG ~1600 mg/dL, IgA 350 mg/dL, and IgM 280 mg/dL.</div><ul><li class="half_rhythm"><div>IgG levels &#x0003e;2,000 mg/dL have been reported numerous times [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>, <a class="bk_pop" href="#prolidase-def.REF.gray.1983.143">Gray et al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>, <a class="bk_pop" href="#prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</a>, <a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</a>, <a class="bk_pop" href="#prolidase-def.REF.lopes.2002.140">Lopes et al 2002</a>, <a class="bk_pop" href="#prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</a>] and as high as 3,680 mg/dL [<a class="bk_pop" href="#prolidase-def.REF.klar.2010.727">Klar et al 2010</a>].</div></li><li class="half_rhythm"><div>IgA levels &#x0003e;500 mg/dL have been reported on several occasions [<a class="bk_pop" href="#prolidase-def.REF.gray.1983.143">Gray et al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>, <a class="bk_pop" href="#prolidase-def.REF.lopes.2002.140">Lopes et al 2002</a>, <a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>] and as high as 850 mg/dL [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>].</div></li><li class="half_rhythm"><div>IgM concentrations as high as 568 mg/dL have been described [<a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</a>].</div></li></ul></li><li class="half_rhythm"><div>Hypocomplementemia. Levels of C3 ranging from 30 to 74 mg/dL (normal: 75-175 mg/dL) have been published [<a class="bk_pop" href="#prolidase-def.REF.klar.2010.727">Klar et al 2010</a>], with C4 as low as 9 mg/dL (normal: 20-40 mg/dL) [<a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al 1994</a>, <a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</a>].</div></li></ul><p><b>Biochemical.</b> Prolidase deficiency is characterized by massive imidodipeptiduria* (10-30 mmol/day) on urine amino acid analysis [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>].</p><ul><li class="half_rhythm"><div>In individuals with prolidase deficiency imidodipeptiduria has been detected as early as in the newborn period, even in the absence of signs or symptoms of the disease. (This finding has been used as the basis for urinary <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> in Quebec [<a class="bk_pop" href="#prolidase-def.REF.lemieux.1984.145">Lemieux et al 1984</a>].)</div></li><li class="half_rhythm"><div>Under normal circumstances the urinary excretion of glycylproline is negligible [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>]; thus, the absence of detectable imidodipeptiduria in properly processed samples is sufficient evidence to rule out a diagnosis of prolidase deficiency [<a class="bk_pop" href="#prolidase-def.REF.freij.1986.431">Freij &#x00026; Der Kaloustian 1986</a>].</div></li></ul><p>Click <a href="/books/NBK299584/bin/prolidase-def-detect-imidodipeptiduria.pdf">here</a> (pdf) for information on laboratory methods used to detect imidodipeptiduria.</p><p>Other biochemical findings:</p><ul><li class="half_rhythm"><div>The concentration of imidodipeptides is much lower in serum than urine [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>].</div></li><li class="half_rhythm"><div>Gly-Pro has been reported in the plasma by some investigators [<a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>], but not others [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>].</div></li><li class="half_rhythm"><div>CSF amino acid analysis was normal in the first report of probable prolidase deficiency [<a class="bk_pop" href="#prolidase-def.REF.goodman.1968.152">Goodman et al 1968</a>].</div></li></ul><p>*Note: A number of published reports mistakenly refer to imidodipeptiduria as "iminodipeptiduria." Iminodipeptides are dipeptides in which proline or hydroxyproline is the N-terminal amino acid (i.e., Pro/Hyp-X, for example prolylglycine), whereas imidodipeptides are dipeptides in which proline or hydroxyproline is the C-terminal amino acid (i.e., X-Pro/Hyp, for example glycylproline).</p></div><div id="prolidase-def.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of prolidase deficiency <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (who has the characteristic clinical findings and imidodipeptiduria) by detection of either <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>PEPD</i> pathogenic variants (see <a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.summary_of_molecular_gen/?report=objectonly" target="object" rid-figpopup="figprolidasedefTsummaryofmoleculargen" rid-ob="figobprolidasedefTsummaryofmoleculargen">Table 2</a>) or reduced prolidase enzyme activity.</p><p><b>Molecular genetic testing</b> approaches include <b>single <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and <b><a class="def" href="/books/n/gene/glossary/def-item/targeted-analysis-for-pathogenic-variants/">targeted analysis for pathogenic variants</a></b>.</p><ul><li class="half_rhythm"><div><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> For most individuals, <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>PEPD</i> is performed first, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div><b>Targeted analysis for pathogenic variants.</b> For Amish from Geauga County, Ohio and Druze and Arab Muslims from northern Israel, testing for the founder variants <a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.pepd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figprolidasedefTpepdpathogenicvariants" rid-ob="figobprolidasedefTpepdpathogenicvariants">p.Arg265Ter</a> and <a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.pepd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figprolidasedefTpepdpathogenicvariants" rid-ob="figobprolidasedefTpepdpathogenicvariants">p.Ser202Phe</a>, respectively, may be performed first followed by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified.</div></li></ul><div id="prolidase-def.T.summary_of_molecular_gen" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Prolidase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299584/table/prolidase-def.T.summary_of_molecular_gen/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prolidase-def.T.summary_of_molecular_gen_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variants Detected</th><th id="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEPD</i></td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">28/30&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions</td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/30&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_2" rowspan="2" colspan="1" scope="row" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants</td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.pepd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figprolidasedefTpepdpathogenicvariants" rid-ob="figobprolidasedefTpepdpathogenicvariants">p.Arg265Ter</a></td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4/4&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.pepd_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figprolidasedefTpepdpathogenicvariants" rid-ob="figobprolidasedefTpepdpathogenicvariants">p.Ser202Phe</a></td><td headers="hd_h_prolidase-def.T.summary_of_molecular_gen_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">17/20&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="prolidase-def.TF.2.1"><p class="no_margin">See <a href="/books/NBK299584/#prolidase-def.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="prolidase-def.TF.2.2"><p class="no_margin">See <a href="#prolidase-def.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="prolidase-def.TF.2.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="prolidase-def.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#prolidase-def.REF.lupi.2008.739">Lupi et al [2008]</a></p></div></dd><dt>5. </dt><dd><div id="prolidase-def.TF.2.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="prolidase-def.TF.2.6"><p class="no_margin">Amish from Geauga County, Ohio [<a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>]</p></div></dd><dt>7. </dt><dd><div id="prolidase-def.TF.2.7"><p class="no_margin">Druze and Arab Muslims from northern Israel [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>]</p></div></dd></dl></div></div></div><p><b>Measurement of prolidase enzyme activity.</b> In <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, prolidase enzyme activity in erythrocytes, leukocytes, or cultured fibroblasts ranges from none to &#x0003c;10% [<a class="bk_pop" href="#prolidase-def.REF.lupi.2008.739">Lupi et al 2008</a>].</p><p>Click <a href="/books/NBK299584/bin/prolidase-def-diagnosis.pdf">here</a> (pdf) for a short review of laboratory techniques used in the diagnosis of prolidase deficiency; see also <a class="bk_pop" href="#prolidase-def.REF.kurien.2006.165">Kurien et al [2006]</a> and <a class="bk_pop" href="#prolidase-def.REF.viglio.2006.1">Viglio et al [2006]</a>.</p></div></div><div id="prolidase-def.Clinical_Characteristics"><h2 id="_prolidase-def_Clinical_Characteristics_">Clinical Characteristics</h2><div id="prolidase-def.Clinical_Description"><h3>Clinical Description</h3><p><b>Skin.</b> The hallmark of prolidase deficiency is severe, chronic, recalcitrant, and painful skin ulcers. The ulcers are located mainly on the lower extremities, particularly the feet. However, individuals are reported with upper extremity involvement, including one with recurrent upper extremity ulceration beginning at age nine years [<a class="bk_pop" href="#prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</a>], one with active ulcers on the hands [<a class="bk_pop" href="#prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</a>], and one with a healed scar from prior ulcers in the dorsum of the hand [<a class="bk_pop" href="#prolidase-def.REF.eldarouti.2013">El-Darouti 2013</a>]. One had scarring from healed ulcers over most of her body; however, at the time of publication active ulcers were mainly on the legs [<a class="bk_pop" href="#prolidase-def.REF.wysocki.1988.161">Wysocki et al 1988</a>].</p><p>Skin ulcers can begin as early as age six months [<a class="bk_pop" href="#prolidase-def.REF.mandel.2000.927">Mandel et al 2000</a>] or as late as age 30 years [<a class="bk_pop" href="#prolidase-def.REF.dyne.2001.635">Dyne et al 2001</a>].</p><p>Ulceration is recurrent, and individual ulcers can take months to heal.</p><p>Typically, no precipitating factors are identified with the appearance of an ulcer, although trauma has been reported as a triggering factor in at least two individuals [<a class="bk_pop" href="#prolidase-def.REF.gray.1983.143">Gray et al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>]. See <a class="figpopup" href="/books/NBK299584/figure/prolidase-def.F1/?report=objectonly" target="object" rid-figpopup="figprolidasedefF1" rid-ob="figobprolidasedefF1">Figure 1</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figprolidasedefF1" co-legend-rid="figlgndprolidasedefF1"><a href="/books/NBK299584/figure/prolidase-def.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figprolidasedefF1" rid-ob="figobprolidasedefF1"><img class="small-thumb" src="/books/NBK299584/bin/prolidase-def-Image001.gif" src-large="/books/NBK299584/bin/prolidase-def-Image001.jpg" alt="Figure 1. . Typical skin ulcerations in individuals with prolidase deficiency." /></a><div class="icnblk_cntnt" id="figlgndprolidasedefF1"><h4 id="prolidase-def.F1"><a href="/books/NBK299584/figure/prolidase-def.F1/?report=objectonly" target="object" rid-ob="figobprolidasedefF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Typical skin ulcerations in individuals with prolidase deficiency. </p></div></div><p>A variety of skin findings can precede the appearance of ulcers by many years [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>]. In the first 20 patients reported [<a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>], eight had telangiectasias of the face, shoulders, and hands; five had scaly, erythematous, maculopapular lesions; and two had purpuric lesions in the absence of hematologic abnormalities. In addition, five had premature graying of the hair.</p><p>Occasional findings:</p><ul><li class="half_rhythm"><div>Lymphedema [<a class="bk_pop" href="#prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</a>, <a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al 2011</a>]</div></li><li class="half_rhythm"><div>Hyperkeratosis of the elbows and knees [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>]</div></li><li class="half_rhythm"><div>Hirsutism [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>]</div></li><li class="half_rhythm"><div>Perioral pitted scars [<a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al 2011</a>] or radial scars [<a class="bk_pop" href="#prolidase-def.REF.tiller.1977.20">Tiller 1977</a>]</div></li></ul><p>As prolidase deficiency is associated with chronic recalcitrant lower extremity ulcers, an increased risk of squamous cell carcinoma of the skin could be expected, and indeed has been reported in one individual [<a class="bk_pop" href="#prolidase-def.REF.fimiani.1999.362">Fimiani et al 1999</a>].</p><p><b>Dysmorphic facial features.</b> Although not a universal finding, facial features typically described include prominent forehead, widely spaced eyes, proptosis, depressed nasal bridge, prognathism, thin vermilion of the upper lip, and low anterior and posterior hairlines [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>, <a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al 2015</a>]. See <a class="figpopup" href="/books/NBK299584/figure/prolidase-def.F2/?report=objectonly" target="object" rid-figpopup="figprolidasedefF2" rid-ob="figobprolidasedefF2">Figure 2</a>.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figprolidasedefF2" co-legend-rid="figlgndprolidasedefF2"><a href="/books/NBK299584/figure/prolidase-def.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figprolidasedefF2" rid-ob="figobprolidasedefF2"><img class="small-thumb" src="/books/NBK299584/bin/prolidase-def-Image002.gif" src-large="/books/NBK299584/bin/prolidase-def-Image002.jpg" alt="Figure 2. . Prominent forehead, proptosis, depressed nasal bridge, and thin vermilion of the upper lip can be appreciated." /></a><div class="icnblk_cntnt" id="figlgndprolidasedefF2"><h4 id="prolidase-def.F2"><a href="/books/NBK299584/figure/prolidase-def.F2/?report=objectonly" target="object" rid-ob="figobprolidasedefF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Prominent forehead, proptosis, depressed nasal bridge, and thin vermilion of the upper lip can be appreciated. </p></div></div><p><b>Neurologic manifestations.</b> Intellectual disability of variable degree has been described in approximately 75% of individuals with prolidase deficiency [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>]. <a class="figpopup" href="/books/NBK299584/table/prolidase-def.T.iq_scores_reported_in_in/?report=objectonly" target="object" rid-figpopup="figprolidasedefTiqscoresreportedinin" rid-ob="figobprolidasedefTiqscoresreportedinin">Table 3</a> summarizes IQ scores reported in the medical literature to date.</p><ul><li class="half_rhythm"><div>In a review 12 of 30 individuals with molecularly confirmed prolidase deficiency had intellectual disability [<a class="bk_pop" href="#prolidase-def.REF.lupi.2008.739">Lupi et al 2008</a>].</div></li><li class="half_rhythm"><div>In a case series of 12 individuals with prolidase deficiency, one had speech delay, two had mild developmental delay, and six had intellectual disability; three had no delays [<a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al 2015</a>].</div></li><li class="half_rhythm"><div>In a case series of 20 Druze and Arab Muslims with prolidase deficiency living in northern Israel all had some degree of developmental delay, mainly moderate cognitive or speech delay [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>]. More specifically, two had speech delay, eight had mild developmental delay, five had moderate delay, and three had severe delay.</div></li></ul><div id="prolidase-def.T.iq_scores_reported_in_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>IQ Scores Reported in Individuals with Prolidase Deficiency</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299584/table/prolidase-def.T.iq_scores_reported_in_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prolidase-def.T.iq_scores_reported_in_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IQ Score</th><th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Test Used</th><th id="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">30</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NR</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.arata.1979.62">Arata et al [1979]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">48</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NR</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al [1981]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">52</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WISC-R</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al [1984]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">52</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NR</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.sekiya.1985.125">Sekiya et al [1985]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">55</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WISC-R</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.monafo.2000.227">Monafo et al [2000]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">61</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WISC-R</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.tiller.1977.20">Tiller [1977]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">66</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NR</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al [1994]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">74</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WISC-R</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al [2011]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">85</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">WISC-R</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.powell.1974.505">Powell et al [1974]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">87</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Peabody Picture Vocabulary Test, Form B</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#prolidase-def.REF.powell.1977.242">Powell et al [1977]</a></td></tr><tr><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">80-90</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NR</td><td headers="hd_h_prolidase-def.T.iq_scores_reported_in_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><a class="bk_pop" href="#prolidase-def.REF.goodman.1968.152">Goodman et al [1968]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">NR = not reported; WISC-R = Wechsler Intelligence Scale for Children &#x02013; Revised</p></div></dd></dl></div></div></div><p>Microcephaly was described in five of 11 individuals [<a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al 2015</a>].</p><p>Seizures have been described in rare cases [<a class="bk_pop" href="#prolidase-def.REF.de_rijcke.1989.309">De Rijcke et al 1989</a>, <a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>, <a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>].</p><p>Brain MRI findings include:</p><ul><li class="half_rhythm"><div>Multiple microthromboses bilaterally in the cerebral white matter [<a class="bk_pop" href="#prolidase-def.REF.arata.1991.124">Arata et al 1991</a>]</div></li><li class="half_rhythm"><div>Multiple bilateral subcortical white matter lesions (mainly in the parieto-occipital area), accompanied by leptomeningeal enhancement (one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual) [<a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>]</div></li><li class="half_rhythm"><div>Findings compatible with vasculitis [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>]</div></li><li class="half_rhythm"><div>Normal (one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual) [<a class="bk_pop" href="#prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</a>]</div></li></ul><p>On nerve conduction studies one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had decreased amplitude of motor action potentials and sensory action potentials [<a class="bk_pop" href="#prolidase-def.REF.cantatore.1993.410">Cantatore et al 1993</a>].</p><p><b>Organomegaly.</b> Hepatomegaly and splenomegaly are common [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>] and variable in severity; in one instance massive splenomegaly (spleen measuring 35 cm) has been reported [<a class="bk_pop" href="#prolidase-def.REF.nasser.2015.169">Nasser et al 2015</a>].</p><p>Liver enzymes may be mildly elevated [<a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>, <a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>].</p><p><b>Hematologic manifestations.</b> Anemia can be either mild microcytic hypochromic anemia [<a class="bk_pop" href="#prolidase-def.REF.powell.1974.505">Powell et al 1974</a>, <a class="bk_pop" href="#prolidase-def.REF.powell.1977.242">Powell et al 1977</a>, <a class="bk_pop" href="#prolidase-def.REF.pedersen.1983.785">Pedersen et al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.milligan.1989.405">Milligan et al 1989</a>] or normocytic normochromic anemia [<a class="bk_pop" href="#prolidase-def.REF.dunn.2011.194">Dunn et al 2011</a>].</p><p>Hemolysis has been described [<a class="bk_pop" href="#prolidase-def.REF.lapiere.1969.353">Lapiere &#x00026; Nusgens 1969</a>], with reticulocytosis varying from 5.9% [<a class="bk_pop" href="#prolidase-def.REF.powell.1977.242">Powell et al 1977</a>] to 8.6% [<a class="bk_pop" href="#prolidase-def.REF.powell.1974.505">Powell et al 1974</a>].</p><p>Thrombocytopenia is fairly common [<a class="bk_pop" href="#prolidase-def.REF.powell.1974.505">Powell et al 1974</a>, <a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>, <a class="bk_pop" href="#prolidase-def.REF.kavala.2006.24">Kavala et al 2006</a>, <a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>, <a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>].</p><p><b>Immunologic manifestations.</b> Recurrent episodes of otitis media, sinusitis, pneumonia, and gastroenteritis are common [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>].</p><p>Elevated levels of IgG, IgA and IgM, and hypocomplementemia have been reported [<a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al 1994</a>], as has decreased neutrophil chemotaxis [<a class="bk_pop" href="#prolidase-def.REF.cleary.1994.345">Cleary et al 1994</a>, <a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</a>, <a class="bk_pop" href="#prolidase-def.REF.lopes.2002.140">Lopes et al 2002</a>]. Serum levels of C1q have been normal [<a class="bk_pop" href="#prolidase-def.REF.gray.1983.143">Gray et al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.kurien.2013.674">Kurien et al 2013</a>].</p><p>Increased serum IgE levels have been reported [<a class="bk_pop" href="#prolidase-def.REF.di_rocco.2007.814">Di Rocco et al 2007</a>, <a class="bk_pop" href="#prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</a>, <a class="bk_pop" href="#prolidase-def.REF.klar.2010.727">Klar et al 2010</a>]:</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#prolidase-def.REF.martins.2000.75">Martins et al [2000]</a> reported a patient with an IgE level of 20,000 IU/mL, which was as high as 77,600 IU/mL on follow up, with a Grimbacher score of 34 [<a class="bk_pop" href="#prolidase-def.REF.lopes.2002.140">Lopes et al 2002</a>].</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#prolidase-def.REF.fukumura.2009.150">Fukumura et al [2009]</a> reported an individual with a level of 23,000 IU/mL.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#prolidase-def.REF.hershkovitz.2006.435">Hershkovitz et al [2006]</a> reported a patient with levels of 1,000-2,000 IU/mL with a Grimbacher score of 41, suggestive of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> hyper IgE syndrome.</div></li></ul><p><b>Pulmonary manifestations.</b> Asthma-like chronic reactive airway disease was described in three of four Amish individuals with prolidase deficiency [<a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>].</p><p>Bronchiectasis, chronic lipoid pneumonia, and a cystic fibrosis <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> including elevated sweat chloride and transepithelial potential difference has been described [<a class="bk_pop" href="#prolidase-def.REF.luder.2007.656">Luder et al 2007</a>].</p><p>One male developed severe progressive restrictive lung disease at age 45 years [<a class="bk_pop" href="#prolidase-def.REF.luder.2007.656">Luder et al 2007</a>].</p><p>A Druze woman age 24 years had progressive lung disease with chest CT findings of mainly cystic lung lesions and ground glass opacity [<a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>]. She experienced further deterioration in her pulmonary function and secondary pulmonary hypertension, and became oxygen dependent.</p><p>An Amish boy age six years with pulmonary hypertension required supplemental oxygen [<a class="bk_pop" href="#prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</a>].</p><p><b>Systemic lupus erythematosus-like findings.</b> An association between systemic lupus erythematosus (SLE) and prolidase deficiency has been described in at least ten individuals, including three of 23 individuals from northern Israel [<a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al 2012</a>].</p><p>This association, first described by <a class="bk_pop" href="#prolidase-def.REF.bissonnette.1993.818">Bissonnette et al [1993]</a> in a female age 16 years, included Raynaud's phenomenon, photosensitivity, arthritis, nephritis (with segmental mesangial deposits of IgA, IgM, and C3), antinuclear antibodies 1:650, and a positive rheumatoid factor.</p><p><a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al [1997]</a> reported two cousins with prolidase deficiency and SLE:</p><ul><li class="half_rhythm"><div>One had a malar facial rash, joint swellings, thrombocytopenia, neutropenia, proteinuria, pericarditis, hypocomplementemia, positive antinuclear antibody test (ANA), and strongly positive anti-dsDNA;</div></li><li class="half_rhythm"><div>The other had recurrent mouth ulcers, a malar rash, thrombocytopenia, neutropenia, positive ANA, positive anti-dsDNA, and positive pANCA.</div></li></ul><p>A boy age 11 years had photosensitivity, malar erythema, and a positive ANA of 1:40 [<a class="bk_pop" href="#prolidase-def.REF.cabrera.2004.684">Cabrera et al 2004</a>].</p><p>A boy age six years diagnosed with SLE was treated for two years with steroids and azathioprine, with amelioration of the immunologic abnormalities but worsening of the skin lesions [<a class="bk_pop" href="#prolidase-def.REF.lupi.2004.500">Lupi et al 2004</a>].</p><p>A male age 25 years had bilateral and symmetric synovitis affecting hands, elbows, and knees, a positive rheumatoid factor (516 IU/mL) and homogeneous ANA (1:640), and low C4 and CH50 (0.07 g/L and 61%) [<a class="bk_pop" href="#prolidase-def.REF.marotte.2010.88">Marotte et al 2010</a>]. He fulfilled the American College of Rheumatology (ACR) criteria for rheumatoid arthritis and SLE (rhupus). Although he was diagnosed with prolidase deficiency based on increased imidodipeptiduria, prolidase enzymatic activity was not measured and <i>PEPD</i> sequencing was not performed. This patient did have increased bone turnover, a known cause of imidodipeptiduria in the absence of prolidase deficiency.</p><p>An Amish boy age 2.5 years with fever of unknown etiology had urinalysis with 2+ proteinuria and hypoalbuminemia, ANA of 1:1080 with speckled pattern, and a positive anti-dsDNA [<a class="bk_pop" href="#prolidase-def.REF.dsouza.2006">D'Souza et al 2006</a>].</p><p>Of two sibs reported by <a class="bk_pop" href="#prolidase-def.REF.klar.2010.727">Klar et al [2010]</a>:</p><ul><li class="half_rhythm"><div>A girl age eight years had Raynaud's phenomenon, a positive ANA (1:1280; homogenous pattern), a positive anti ds-DNA &#x0003e;1:160, positive anti-ENA, anti-RNP and anti-Smith;</div></li><li class="half_rhythm"><div>Her brother, age 12 years, had Raynaud's phenomenon, a positive ANA (1:40; homogeneous) and anti ds-DNA (1.6 &#x003bc;g/mL), and low C3 (30-74 mg/dL).</div></li></ul><p>An individual with positive ANA and anti-dsDNA titers, as well as low complement levels had no hematologic, renal, or articular problems; although he was given a diagnosis of SLE, he did not fulfill ACR diagnostic criteria [<a class="bk_pop" href="#prolidase-def.REF.di_rocco.2007.814">Di Rocco et al 2007</a>].</p><p><a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al [2010]</a> reported two individuals:</p><ul><li class="half_rhythm"><div>One with Coombs-positive hemolytic anemia, severe medication-resistant thrombocytopenia which required splenectomy, high levels of ANA and anti-cardiolipin antibodies, and a strongly positive anti-dsDNA;</div></li><li class="half_rhythm"><div>One with aphthous stomatitis, macroscopic hematuria and proteinuria eventually leading to renal failure (with a renal biopsy compatible with lupus nephritis), seizures, pancytopenia, Coombs-positive hemolytic anemia, hypocomplementemia, and elevated ANA and anti-dsDNA antibodies).</div></li></ul><p><a class="bk_pop" href="#prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel et al [2012]</a> reported three individuals with the SLE/prolidase deficiency association:</p><ul><li class="half_rhythm"><div>A boy age 4.5 years with a rash consistent with hypertrophic discoid lupus on biopsy, proteinuria and mild hematuria with a renal biopsy consistent with WHO Class IV lupus nephritis, low C3 and C4 levels, positive ANA (1:640; homogeneous pattern), anti ds-DNA, anti-RNP, anti-SM, anti Ro (SS-A) and anti La (SS-B)</div></li><li class="half_rhythm"><div>A girl age 16 years with macroscopic hematuria and proteinuria, with a renal biopsy demonstrating WHO Class IV lupus nephritis; she had low C3 and C4, as well as a highly positive ANA and positive anti ds-DNA titer</div></li><li class="half_rhythm"><div>A woman age 24 years with thrombocytopenia, a positive Coombs test, low C3 and C3 levels, and positive ANA and anti ds-DNA titers</div></li></ul><p>Positive ANA, anti-dsDNA, anti-ENA (anti-Ro), anti-Sm and anti-chromatin have been found in individuals with prolidase deficiency even in the absence of clinical findings of SLE [<a class="bk_pop" href="#prolidase-def.REF.kurien.2013.674">Kurien et al 2013</a>].</p><p><b>Bone manifestations.</b> Among 12 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported by <a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al [2015]</a>, short stature was described in seven, osteopenia in six, and genu valgum in four.</p><p>Other bone findings include spina bifida of C3 and 13 thoracic vertebrae [<a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>]; fusion of C2 and C3 [<a class="bk_pop" href="#prolidase-def.REF.lacarbonara.2014.224">Lacarbonara et al 2014</a>]; and delayed bone age [<a class="bk_pop" href="#prolidase-def.REF.pedersen.1983.785">Pedersen at al 1983</a>, <a class="bk_pop" href="#prolidase-def.REF.lacarbonara.2014.224">Lacarbonara et al 2014</a>].</p><p>Digital clubbing, in the presence and in the absence of pulmonary abnormalities, has also been reported [<a class="bk_pop" href="#prolidase-def.REF.luder.2007.656">Luder et al 2007</a>, <a class="bk_pop" href="#prolidase-def.REF.kelly.2010.1031">Kelly et al 2010</a>].</p><p><b>Other manifestations</b></p><ul><li class="half_rhythm"><div>Joint laxity [<a class="bk_pop" href="#prolidase-def.REF.pasquali_ronchetti.1991.439">Pasquali Ronchetti et al 1991</a>, <a class="bk_pop" href="#prolidase-def.REF.lombeck.1986.571">Lombeck et al 1986</a>, <a class="bk_pop" href="#prolidase-def.REF.kavala.2006.24">Kavala et al 2006</a>], including hip dislocation [<a class="bk_pop" href="#prolidase-def.REF.arata.1979.62">Arata et al 1979</a>, <a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>]</div></li><li class="half_rhythm"><div>Protuberant abdomen in five of the first 17 cases reported [<a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>]</div></li><li class="half_rhythm"><div>Obesity [<a class="bk_pop" href="#prolidase-def.REF.andry.1992.818">Andry et al 1992</a>]</div></li><li class="half_rhythm"><div>Optic and chorioretinal atrophy [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>], keratitis [<a class="bk_pop" href="#prolidase-def.REF.ogata.1981.689">Ogata et al 1981</a>, <a class="bk_pop" href="#prolidase-def.REF.freij.1984.561">Freij et al 1984</a>] and pathologic myopia [<a class="bk_pop" href="#prolidase-def.REF.kiratli.1998.49">Kiratli &#x00026; Satilmi&#x0015f; 1998</a>]</div></li><li class="half_rhythm"><div>Erosive cystitis (one individual) [<a class="bk_pop" href="#prolidase-def.REF.milligan.1989.405">Milligan et al 1989</a>]</div></li><li class="half_rhythm"><div>Dental dysplasia [<a class="bk_pop" href="#prolidase-def.REF.moulonguet.1989.792">Moulonguet et al 1989</a>]</div></li><li class="half_rhythm"><div>Autoimmune adrenal failure (one individual) [<a class="bk_pop" href="#prolidase-def.REF.luder.2007.656">Luder et al 2007</a>]</div></li></ul><p><b>Prognosis.</b> The severity of prolidase deficiency is quite variable: in some individuals skin ulcerations lead to amputation of one [<a class="bk_pop" href="#prolidase-def.REF.lupi.2006.e58">Lupi et al 2006</a>] or all toes [<a class="bk_pop" href="#prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</a>], whereas others remain entirely asymptomatic.</p><p>Two individuals diagnosed through systematic urinary <a class="def" href="/books/n/gene/glossary/def-item/newborn-screening/">newborn screening</a> in Quebec [<a class="bk_pop" href="#prolidase-def.REF.lemieux.1984.145">Lemieux et al 1984</a>] remained asymptomatic 14 years later [<a class="bk_pop" href="#prolidase-def.REF.hechtman.2001">Hechtman 2001</a>].</p><p>A man age 26 years, whose younger sister was <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, had imidodipeptiduria and prolidase deficiency in erythrocytes but no clinical manifestations [<a class="bk_pop" href="#prolidase-def.REF.isemura.1979.401">Isemura et al 1979</a>].</p><p>A woman age 29 years, the sister of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, had absence of prolidase activity in serum or erythrocytes, but no skin ulcers or other clinical manifestations of prolidase deficiency [<a class="bk_pop" href="#prolidase-def.REF.lupi.2006.e58">Lupi et al 2006</a>].</p><p>In most instances, individuals with prolidase deficiency experience severe morbidity and early death, usually due to infection.</p><p>The individual with probable prolidase deficiency reported by <a class="bk_pop" href="#prolidase-def.REF.goodman.1968.152">Goodman et al [1968]</a> had died of influenza by the time of a follow-up biochemical report four years later [<a class="bk_pop" href="#prolidase-def.REF.buist.1972.1113">Buist et al 1972</a>]. He was about age 50 years at the time of death [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>].</p><p>The female reported by <a class="bk_pop" href="#prolidase-def.REF.lapiere.1969.353">Lapiere &#x00026; Nusgens [1969]</a> died at age 36 years [<a class="bk_pop" href="#prolidase-def.REF.endo.1990.162">Endo et al 1990</a>]; she had superinfection of skin ulcers with <i>Pseudomonas aeruginosa</i>, which lead to septic shock and disseminated intravascular coagulation [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>].</p><p>A female died of a fungal infection and disseminated intravascular coagulation [<a class="bk_pop" href="#prolidase-def.REF.sekiya.1985.125">Sekiya et al 1985</a>].</p><p>A girl age 16 years with prolidase deficiency and SLE developed cellulitis of the leg, followed by adult respiratory distress syndrome and death [<a class="bk_pop" href="#prolidase-def.REF.bissonnette.1993.818">Bissonnette et al 1993</a>].</p><p>A male died at 15 years of age of unknown reasons [<a class="bk_pop" href="#prolidase-def.REF.endo.1990.162">Endo et al 1990</a>].</p><p>A patient age 15 years died of terminal liver failure and cardiac failure [<a class="bk_pop" href="#prolidase-def.REF.royce.2002">Royce &#x00026; Steinmann 2002</a>].</p><p>A patent age 11 years died of unknown causes [<a class="bk_pop" href="#prolidase-def.REF.besio.2015.53">Besio et al [2015]</a>.</p><p>A boy age eight years with prolidase deficiency and SLE died after developing a facial abscess and septicemia [<a class="bk_pop" href="#prolidase-def.REF.shrinath.1997.441">Shrinath et al 1997</a>].</p><p>The youngest reported death was at age four years [<a class="bk_pop" href="#prolidase-def.REF.mandel.2000.927">Mandel et al 2000</a>].</p></div><div id="prolidase-def.GenotypePhenotype_Correlat"><h3>Genotype-Phenotype Correlations</h3><p>There are no known <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>. Marked phenotypic variability has been found among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals from the same family (who have the same pathogenic variants) [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>].</p></div><div id="prolidase-def.Nomenclature"><h3>Nomenclature</h3><p>Prolidase deficiency was also known as hyperimidodipeptiduria, although increased excretion of imidodipeptides is not exclusive to prolidase deficiency. Other names used in the past include imidodipeptidase deficiency and peptidase D deficiency.</p></div><div id="prolidase-def.Prevalence"><h3>Prevalence</h3><p>Approximately 90 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have been reported in the literature; however, prolidase deficiency likely remains underdiagnosed as a result of under-recognition by physicians.</p><p>The Qu&#x000e9;bec Newborn Urine Screening Program (Programme qu&#x000e9;b&#x000e9;cois de d&#x000e9;pistage neonatal Urinaire, PQDNU) identified two <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> infants out of 2,469,929 screened between 1973 and 2006, for an incidence of 1:1,235,000 [<a class="bk_pop" href="#prolidase-def.REF.renaud.2009">Renaud &#x00026; Dagenais 2009</a>]. Thus, a few thousand cases would be predicted to exist worldwide, as opposed to only 90 cases reported to date.</p><p>Prolidase deficiency has been diagnosed throughout the world [<a class="bk_pop" href="#prolidase-def.REF.lupi.2008.739">Lupi et al 2008</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> has been described in the Geauga County settlement in Ohio [<a class="bk_pop" href="#prolidase-def.REF.wang.2006.580">Wang et al 2006</a>], as well as in the Druze population in northern Israel, the latter with a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> frequency of 1:21 [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2008.903">Falik-Zaccai et al 2008</a>].</p></div></div><div id="prolidase-def.Genetically_Related_Alleli"><h2 id="_prolidase-def_Genetically_Related_Alleli_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with mutation of <i>PEPD</i>.</p></div><div id="prolidase-def.Differential_Diagnosis"><h2 id="_prolidase-def_Differential_Diagnosis_">Differential Diagnosis</h2><div id="prolidase-def.Disorders_with_Imidodipept"><h3>Disorders with Imidodipeptiduria</h3><p>Imidodipeptiduria has been described in bone disorders, presumably originating from collagen under conditions of high bone turnover.</p><p>Glycylproline has been found in the urine of:</p><ul><li class="half_rhythm"><div>A child with severe bone disease and hyperphosphatasia [<a class="bk_pop" href="#prolidase-def.REF.seakins.1963.215">Seakins 1963</a>];</div></li><li class="half_rhythm"><div>Two sisters with multiple fractures and striking bone deformities of unknown etiology [<a class="bk_pop" href="#prolidase-def.REF.alderman.1969.692">Alderman et al 1969</a>];</div></li><li class="half_rhythm"><div>A woman age 28 years with osteomalacia and severe hyperparathyroidism who excreted large amounts of glycylproline, equivalent to ~1 g/day [<a class="bk_pop" href="#prolidase-def.REF.cahill.1970.519">Cahill et al 1970</a>];</div></li><li class="half_rhythm"><div>Three individuals with rickets [<a class="bk_pop" href="#prolidase-def.REF.scriver.1964.357">Scriver 1964</a>] who excreted decreasing amounts of glycylproline concomitant with clinical improvement, until the imidodipeptiduria disappeared with recovery from the disease.</div></li></ul></div><div id="prolidase-def.Disorders_with_Skin_Ulcers"><h3>Disorders with Skin Ulcers</h3><p><a href="/books/n/gene/werner/">Werner syndrome</a> is characterized by cancer predisposition and the premature appearance of features associated with normal aging. Findings shared by prolidase deficiency and Werner syndrome are chronic lower extremity ulcers [<a class="bk_pop" href="#prolidase-def.REF.sternberg.1982.293">Sternberg et al 1982</a>, <a class="bk_pop" href="#prolidase-def.REF.yeong.2004.86">Yeong &#x00026; Yang 2004</a>, <a class="bk_pop" href="#prolidase-def.REF.noda.2011.e54">Noda et al 2011</a>], premature graying of the hair, and a "bird-like" facial appearance [<a class="bk_pop" href="#prolidase-def.REF.milligan.1989.405">Milligan et al 1989</a>, <a class="bk_pop" href="#prolidase-def.REF.pasquali_ronchetti.1991.439">Pasquali Ronchetti et al 1991</a>, <a class="bk_pop" href="#prolidase-def.REF.zanaboni.1994.13">Zanaboni et al 1994</a>]. Imidodipeptiduria has not been reported in Werner syndrome. Werner syndrome is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>WRN</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><a href="/books/n/gene/sickle/">Sickle cell disease</a> (SCD) is characterized by intermittent vaso-occlusive events and chronic hemolytic anemia. Leg ulcers which are relatively common in SCD were found in 2.5% of patients from the Cooperative Study of Sickle Cell Disease in the US [<a class="bk_pop" href="#prolidase-def.REF.koshy.1989.1403">Koshy et al 1989</a>], in 43% in the Jamaican Cohort Study [<a class="bk_pop" href="#prolidase-def.REF.clare.2002.567">Clare et al 2002</a>], and in 1.7% [<a class="bk_pop" href="#prolidase-def.REF.akinyanju.1979.87">Akinyanju &#x00026; Akinsete 1979</a>] to 13.2% [<a class="bk_pop" href="#prolidase-def.REF.knoxmacaulay.1983.411">Knox-Macaulay 1983</a>] of Africans.</p><p>Although urinary excretion of hydroxyproline has been shown to be significantly increased in persons with sickle cell disease compared to controls [<a class="bk_pop" href="#prolidase-def.REF.mohammed.1991.285">Mohammed et al 1991</a>] (presumably due to bone involvement), glycylprolinuria has not been reported in SCD. More importantly, although individuals with prolidase deficiency can have mild findings of hemolysis, they do not have veno-occlusive episodes. SCD is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HBB</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><a href="/books/n/gene/b-thal/">Beta-thalassemia</a> is characterized by reduced synthesis of the hemoglobin subunit beta (hemoglobin beta chain) that results in reduced amounts of hemoglobin A, microcytic hypochromic anemia, and an abnormal peripheral blood smear with nucleated red blood cells. Affected individuals with other hemoglobinopathies such as &#x003b2;-thalassemia can also have chronic leg ulcers [<a class="bk_pop" href="#prolidase-def.REF.stevens.1977.1558">Stevens et al 1977</a>, <a class="bk_pop" href="#prolidase-def.REF.gimmon.1982.320">Gimmon et al 1982</a>, <a class="bk_pop" href="#prolidase-def.REF.levin.2011.316">Levin &#x00026; Koren 2011</a>, <a class="bk_pop" href="#prolidase-def.REF.taher.2013">Taher et al 2013</a>], but again no imidopeptiduria is known to occur. Persons with prolidase deficiency should have a normal hemoglobin electrophoretic pattern. &#x003b2;-thalassemia is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HBB</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p>Acquired causes of lower-extremity ulcers include arterial insufficiency, venous insufficiency, pressure ulcers, vasculitis, systemic lupus erythematosus, and infectious etiologies, among others. Although glycineprolinuria could be anticipated in cases of secondary skin ulcers given the high content of collagen in the dermis, a number of patients with extensive skin ulceration have been tested, and imidodipeptiduria was only found when accompanied by severe concurrent bone disease (e.g., multiple fractures) [<a class="bk_pop" href="#prolidase-def.REF.sheffield.1977.578">Sheffield et al 1977</a>].</p></div><div id="prolidase-def.Disorders_with_Hyper_IgE"><h3>Disorders with Hyper IgE</h3><p><a href="/books/n/gene/higes/">Autosomal dominant hyper IgE syndrome</a> (AD-HIES) is a primary immune deficiency syndrome characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities like osteopenia, minimal trauma fractures, and scoliosis. AD-HIES is caused by mutation of <i>STAT3</i>. A Grimbacher score of &#x0003e;40 is suggestive of AD-HIES.</p><p>Autosomal recessive hyper IgE syndrome (AR-HIES) (OMIM <a href="http://omim.org/entry/243700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">243700</a>) is a distinct clinical disorder, characterized by elevated serum concentration of IgE, severe eczema, and recurrent skin and lung infections [<a class="bk_pop" href="#prolidase-def.REF.renner.2004.93">Renner et al 2004</a>], all of which can also be seen in prolidase deficiency. Prolidase deficiency differs from AD-HIES by an increased incidence of neurologic abnormalities, an increased occurrence of viral infections of the skin (e.g., <i>Molluscum contagiosum</i>, warts) and virus-driven malignancies, as well as absence of the non-immunologic findings of AD-HIES (e.g., connective tissue, skeletal and dental involvement) [<a class="bk_pop" href="#prolidase-def.REF.renner.2004.93">Renner et al 2004</a>]. AR-HIES is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>DOCK8.</i></p></div></div><div id="prolidase-def.Management"><h2 id="_prolidase-def_Management_">Management</h2><div id="prolidase-def.Evaluations_Following_Init"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with prolidase deficiency, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Review of systems to assess for the possibility of pulmonary complications. In those with a history of pulmonary complications, consider chest imaging, pulmonary function tests, an echocardiogram to assess for pulmonary hypertension, and consultation with a pulmonologist.</div></li><li class="half_rhythm"><div>Physical examination to evaluate for splenomegaly. If present, perform an abdominal ultrasound examination to evaluate the extent of splenomegaly.</div></li><li class="half_rhythm"><div>Complete blood count to evaluate for anemia and thrombocytopenia</div></li><li class="half_rhythm"><div>Liver function tests to assess for the possibility of elevated liver enzymes</div></li><li class="half_rhythm"><div>Developmental assessment</div></li><li class="half_rhythm"><div>Consultation with a wound care specialist</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="prolidase-def.Treatment_of_Manifestation"><h3>Treatment of Manifestations</h3><p>No curative treatment is available.</p><p>Care is preferably provided by a multidisciplinary team. Supportive treatment of skin, lung, and immunologic manifestations has been efficacious in some (but not in all) patients. Caution is warranted in the treatment of infections, which can be fulminant and fatal.</p><p>Click <a href="/books/NBK299584/bin/prolidase-def-unsuccessful-treatments.pdf">here</a> (pdf) for further details, including treatments in which only partial or short-term benefit was reported.</p></div><div id="prolidase-def.Prevention_of_Secondary_Co"><h3>Prevention of Secondary Complications</h3><p>Those who have undergone splenectomy should be appropriately immunized and treated promptly with antibiotics at the first sign of infection.</p><p>Antibiotic prophylaxis should also be considered in the appropriate setting.</p></div><div id="prolidase-def.Surveillance"><h3>Surveillance</h3><p>In the absence of formal surveillance guidelines, the authors recommend:</p><ul><li class="half_rhythm"><div>Annual:</div><ul><li class="half_rhythm"><div>Skin examination for evidence of malignant transformation in persons with chronic recalcitrant skin ulcers</div></li><li class="half_rhythm"><div>Complete blood count</div></li><li class="half_rhythm"><div>Liver function tests</div></li><li class="half_rhythm"><div>Abdominal ultrasound examination to assess liver and spleen size</div></li></ul></li><li class="half_rhythm"><div>Follow up as recommended by a pulmonologist and immunologist;</div></li><li class="half_rhythm"><div>Follow-up assessments of motor and cognitive development as recommended for educational planning.</div></li></ul></div><div id="prolidase-def.AgentsCircumstances_to_Avo"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with prolidase deficiency who have splenomegaly should avoid contact sports given the increased risk for splenic rupture.</p></div><div id="prolidase-def.Evaluation_of_Relatives_at"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#prolidase-def.Related_Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="prolidase-def.Therapies_Under_Investigat"><h3>Therapies Under Investigation</h3><p><b>Adenovirus-mediated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> transfer.</b>
<a class="bk_pop" href="#prolidase-def.REF.ikeda.1997.401">Ikeda et al [1997]</a> performed transfer of the human prolidase <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> into fibroblasts from patients with prolidase deficiency. This increased the fibroblast prolidase activity up to 75 times normal.</p><p><b>Intracellular delivery of liposome-encapsulated prolidase.</b>
<a class="bk_pop" href="#prolidase-def.REF.perugini.2005.181">Perugini et al [2005]</a> showed that active prolidase encapsulated in liposomes was completely transported via endocytosis into fibroblasts six days after incubation.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="prolidase-def.Genetic_Counseling"><h2 id="_prolidase-def_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="prolidase-def.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Prolidase deficiency is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="prolidase-def.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>PEPD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The offspring of an individual with prolidase deficiency are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PEPD</i>.</div></li><li class="half_rhythm"><div>A high <a class="def" href="/books/n/gene/glossary/def-item/carrier-rate/">carrier rate</a> for prolidase deficiency exists in certain populations, increasing the risk that an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have a reproductive partner who is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> (see <a href="#prolidase-def.Prevalence">Prevalence</a>). The offspring of such an individual and a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> are at 50% risk of being affected and 50% risk of being obligate heterozygotes.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>PEPD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="prolidase-def.Carrier_Heterozygote_Detec"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>PEPD</i> pathogenic variants in the family.</p></div><div id="prolidase-def.Related_Genetic_Counseling"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are carriers or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="prolidase-def.Prenatal_Testing_and_Preim"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>PEPD</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for prolidase deficiency are possible.</p><p><b>Biochemical genetic testing.</b> Measurement of prolidase activity in amniocytes has been used for <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> [<a class="bk_pop" href="#prolidase-def.REF.mandel.2000.927">Mandel et al 2000</a>]; however, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> is the preferred method if both <i>PEPD</i> pathogenic variants in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member are known.</p><p>Note: Results of prenatal testing cannot be used to predict age of onset or clinical course. Severity of the condition can vary among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals within the same family.</p></div></div><div id="prolidase-def.Resources"><h2 id="_prolidase-def_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/prolidase-deficiency" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Prolidase deficiency</a></div></li><li class="half_rhythm"><div><b>Metabolic Support UK</b></div><div>5 Hilliards Court, Sandpiper Way</div><div>Chester Business Park</div><div>Chester CH4 9QP </div><div>United Kingdom</div><div><b>Phone:</b> 0845 241 2173</div><div><b>Email:</b> contact@metabolicsupportuk.org</div><div><a href="https://www.metabolicsupportuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.metabolicsupportuk.org</a></div></li></ul></div><div id="prolidase-def.Molecular_Genetics"><h2 id="_prolidase-def_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="prolidase-def.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Prolidase Deficiency: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299584/table/prolidase-def.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prolidase-def.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_prolidase-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_prolidase-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_prolidase-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_prolidase-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_prolidase-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_prolidase-def.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5184" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PEPD</i></a></td><td headers="hd_b_prolidase-def.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5184" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19q13<wbr style="display:inline-block"></wbr>​.11</a></td><td headers="hd_b_prolidase-def.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P12955" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xaa-Pro dipeptidase</a></td><td headers="hd_b_prolidase-def.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PEPD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEPD</a></td><td headers="hd_b_prolidase-def.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PEPD[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PEPD</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="prolidase-def.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="prolidase-def.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Prolidase Deficiency (<a href="/omim/170100,613230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299584/table/prolidase-def.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prolidase-def.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/170100" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">170100</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROLIDASE DEFICIENCY</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613230</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PEPTIDASE D; PEPD</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>PEPD</i> comprises 15 exons. There are three transcript variants, variant 1 (<a href="/nuccore/NM_000285.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000285.3</a>) being the longest. Variants 2 and 3 lack two alternate <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> exons in the central <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a>, thus resulting in loss of an internal segment compared to isoform 1. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK299584/#prolidase-def.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> More than 40 individuals with prolidase deficiency have been molecularly characterized. At least 22 different pathogenic variants have been reported to date.</p><ul><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Arg265Ter has been identified in all individuals of Amish heritage with prolidase deficiency from Geauga County, Ohio [Authors, personal observation].</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> p.Ser202Phe is the most common pathogenic variant in Druze and Arab Muslim individuals from northern Israel. Of note, the pathogenic variant p.Ala212Pro was identified in one Arab Muslim family and the pathogenic variant p.Leu368Arg in one Druze family from the same region [<a class="bk_pop" href="#prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai et al 2010</a>].</div></li></ul><div id="prolidase-def.T.pepd_pathogenic_variants" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>PEPD</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK299584/table/prolidase-def.T.pepd_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__prolidase-def.T.pepd_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.605C&#x0003e;T</td><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser202Phe</td><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_3" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_000285.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000285<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_000276.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000276<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.634G&#x0003e;C</td><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala212Pro</td></tr><tr><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.793C&#x0003e;T</td><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg265Ter</td></tr><tr><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1103T&#x0003e;G</td><td headers="hd_h_prolidase-def.T.pepd_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu368Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Prolidase contains 493 amino acids. It is a homodimer, with each subunit binding two manganese ions that are required for full enzymatic activity. The enzyme is required in the final catabolic steps of endogenous and dietary proteins, as it cleaves proline or hydroxyproline when these amino acids are in the C-terminal position. It is thus particularly important in the metabolism of proteins rich in proline and hydroxyproline, such as collagen.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The deficiency of prolidase leads to accumulation of imidodipeptides, or peptides with two amino acids, with a C-terminal proline or hydroxyproline.</p></div><div id="prolidase-def.References"><h2 id="_prolidase-def_References_">References</h2><div id="prolidase-def.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.akinyanju.1979.87">Akinyanju O, Akinsete I. Leg ulceration in sickle cell disease in Nigeria. <span><span class="ref-journal">Trop Geogr Med. </span>1979;<span class="ref-vol">31</span>:87–91.</span> [<a href="/pubmed/483376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 483376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.alderman.1969.692">Alderman MH, Frimpter GW, Isaacs M, Scheiner E. Glycylproline peptiduria in familial hyperostosis of obscure nature. <span><span class="ref-journal">Metabolism. </span>1969;<span class="ref-vol">18</span>:692–9.</span> [<a href="/pubmed/4895065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4895065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.andry.1992.818">Andry P, Bodemer C, Cosson C, Teillac-Hamel D, De Prost Y. Chronic leg ulcer in children with prolidase deficiency. <span><span class="ref-journal">Ann Dermatol Venereol. </span>1992;<span class="ref-vol">119</span>:818–21.</span> [<a href="/pubmed/1301685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1301685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.arata.1991.124">Arata J, Tada J, Yamada T, Oono T, Yasutomi H, Oka E. Angiopathic pathogenesis of clinical manifestations in prolidase deficiency. <span><span class="ref-journal">Arch Dermatol. </span>1991;<span class="ref-vol">127</span>:124–5.</span> [<a href="/pubmed/1986698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1986698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.arata.1979.62">Arata J, Umemura S, Yamamoto Y, Hagiyama M, Nohara N. Prolidase deficiency: its dermatological manifestations and some additional biochemical studies. <span><span class="ref-journal">Arch Dermatol. </span>1979;<span class="ref-vol">115</span>:62–7.</span> [<a href="/pubmed/760660" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 760660</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.besio.2015.53">Besio R, Maruelli S, Gioia R, Villa I, Grabowski P, Gallagher O, Bishop NJ, Foster S, De Lorenzi E, Colombo R, Diaz JL, Moore-Barton H, Deshpande C, Aydin HI, Tokatli A, Kwiek B, Kasapkara CS, Adisen EO, Gurer MA, Di Rocco M, Phang JM, Gunn TM, Tenni R, Rossi A, Forlino A. Lack of prolidase causes a bone phenotype both in human and in mouse. <span><span class="ref-journal">Bone. </span>2015;<span class="ref-vol">72</span>:53–64.</span> [<a href="/pubmed/25460580" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25460580</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.bissonnette.1993.818">Bissonnette R, Friedmann D, Giroux JM, Dolenga M, Hechtman P, Der Kaloustian VM, Dubuc R. Prolidase deficiency: a multisystemic hereditary disorder. <span><span class="ref-journal">J Am Acad Dermatol. </span>1993;<span class="ref-vol">29</span>:818–21.</span> [<a href="/pubmed/8408817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8408817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.buist.1972.1113">Buist NR, Strandholm JJ, Bellinger JF, Kennaway NG. Further studies on a patient with iminodipeptiduria: a probable case of prolidase deficiency. <span><span class="ref-journal">Metabolism. </span>1972;<span class="ref-vol">21</span>:1113–23.</span> [<a href="/pubmed/4674498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4674498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.butbul_aviel.2012.18">Butbul Aviel Y, Mandel H, Avitan Hersh E, Bergman R, Adiv OE, Luder A, Brik R. Prolidase deficiency associated with systemic lupus erythematosus (SLE): single site experience and literature review. <span><span class="ref-journal">Pediatr Rheumatol Online J. </span>2012;<span class="ref-vol">10</span>:18.</span> [<a href="/pmc/articles/PMC3623899/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3623899</span></a>] [<a href="/pubmed/22726576" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22726576</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.cabrera.2004.684">Cabrera HN, Giovanna PD, Bozzini NF, Forlino A. Prolidase deficiency: case reports of two Argentinian brothers. <span><span class="ref-journal">Int J Dermatol. </span>2004;<span class="ref-vol">43</span>:684–6.</span> [<a href="/pubmed/15357754" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15357754</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.cahill.1970.519">Cahill R, Smith R, Westall RG. A detailed study of the urinary peptides in a patient with osteomalacia and hyperparathyroidism. <span><span class="ref-journal">Clin Sci. </span>1970;<span class="ref-vol">38</span>:519–32.</span> [<a href="/pubmed/5428813" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5428813</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.cantatore.1993.410">Cantatore FP, Papadia F, Giannico G, Simonetti S, Carrozzo M. Chronic leg ulcerations resembling vasculitis in two siblings with prolidase deficiency. <span><span class="ref-journal">Clin Rheumatol. </span>1993;<span class="ref-vol">12</span>:410–4.</span> [<a href="/pubmed/8258246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8258246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.clare.2002.567">Clare A, FitzHenley M, Harris J, Hambleton I, Serjeant GR. Chronic leg ulceration in homozygous sickle cell disease: the role of venous incompetence. <span><span class="ref-journal">Br J Haematol. </span>2002;<span class="ref-vol">119</span>:567–71.</span> [<a href="/pubmed/12406102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12406102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.cleary.1994.345">Cleary MA, Heaney M, Couriel JM, Walter JH. Immune function in prolidase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1994;<span class="ref-vol">17</span>:345–8.</span> [<a href="/pubmed/7807949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7807949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.de_rijcke.1989.309">De Rijcke S, De Maubeuge J, Laporte M, Bron D, Hariga C, Ledoux M. Prolidase deficiency. Apropos of a peculiar case. <span><span class="ref-journal">Ann Dermatol Venereol. </span>1989;<span class="ref-vol">116</span>:309–12.</span> [<a href="/pubmed/2675733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2675733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.di_rocco.2007.814">Di Rocco M, Fantasia AR, Taro M, Loy A, Forlino A, Martini A. Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>2007;<span class="ref-vol">30</span>:814.</span> [<a href="/pubmed/17570078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17570078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.dsouza.2006">D'Souza A, Kurien BT, Patel NC, Miller DL, Wang H, Scofield RH. Prolidase deficiency in systemic lupus erythematosus. Abstract 629. Washington, DC: American College of Rheumatology Annual Scientific Meeting; 2006. Available <a href="https://acr.confex.com/acr/2006/webprogram/Paper6124.html" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. Accessed 11-7-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.dunn.2011.194">Dunn R, Varigos G, Winship I. A photographic essay of prolidase deficiency. <span><span class="ref-journal">Clin Dysmorphol. </span>2011;<span class="ref-vol">20</span>:194–9.</span> [<a href="/pubmed/21760498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21760498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.dyne.2001.635">Dyne K, Zanaboni G, Bertazzoni M, Cetta G, Viglio S, Lupi A, Iadarola P. Mild, late-onset prolidase deficiency: another Italian case. <span><span class="ref-journal">Br J Dermatol. </span>2001;<span class="ref-vol">144</span>:635–6.</span> [<a href="/pubmed/11260036" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11260036</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.eldarouti.2013">El-Darouti MA. Stubborn leg ulcers, stiff joints, acral sclerodermoid changes and fragile skin. In: <em>Challenging Cases in Dermatology</em>. London: Springer; 2013:113-7.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.endo.1990.162">Endo F, Tanoue A, Kitano A, Arata J, Danks DM, Lapi&#x000e8;re CM, Sei Y, Wadman SK, Matsuda I. Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes. <span><span class="ref-journal">J Clin Invest. </span>1990;<span class="ref-vol">85</span>:162–9.</span> [<a href="/pmc/articles/PMC296401/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC296401</span></a>] [<a href="/pubmed/1688567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1688567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.falikzaccai.2008.903">Falik-Zaccai TC, Kfir N, Frenkel P, Cohen C, Tanus M, Mandel H, Shihab S, Morkos S, Aaref S, Summar ML, Khayat M. Population screening in a Druze community: the challenge and the reward. <span><span class="ref-journal">Genet Med. </span>2008;<span class="ref-vol">10</span>:903–9.</span> [<a href="/pubmed/19092443" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19092443</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.falikzaccai.2010.46">Falik-Zaccai TC, Khayat M, Luder A, Frenkel P, Magen D, Brik R, Gershoni-Baruch R, Mandel H. A broad spectrum of developmental delay in a large cohort of prolidase deficiency patients demonstrates marked interfamilial and intrafamilial phenotypic variability. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2010;<span class="ref-vol">153B</span>:46–56.</span> [<a href="/pubmed/19308961" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19308961</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.fimiani.1999.362">Fimiani M, Rubegni P, de Aloe G, Bilenchi R, Andreassi L. Squamous cell carcinoma of the leg in a patient with prolidase deficiency. <span><span class="ref-journal">Br J Dermatol. </span>1999;<span class="ref-vol">140</span>:362–3.</span> [<a href="/pubmed/10233241" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10233241</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.freij.1986.431">Freij BJ, Der Kaloustian VM. Prolidase deficiency. A metabolic disorder presenting with dermatologic signs. <span><span class="ref-journal">Int J Dermatol. </span>1986;<span class="ref-vol">25</span>:431–3.</span> [<a href="/pubmed/3771038" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3771038</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.freij.1984.561">Freij BJ, Levy HL, Dudin G, Mutasim D, Deeb M, Der Kaloustian VM. Clinical and biochemical characteristics of prolidase deficiency in siblings. <span><span class="ref-journal">Am J Med Genet. </span>1984;<span class="ref-vol">19</span>:561–71.</span> [<a href="/pubmed/6507502" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6507502</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.fukumura.2009.150">Fukumura A, Asaka T, Kasakura H, Doshita T, Chen W, Yokoji H, Tsuchishima S, Matsushima A, Takeda K, Takase S. Prolidase deficiency with various clinical conditions including hyper-IgE and multiple lung bulla formation. <span><span class="ref-journal">Nihon Naika Gakkai Zasshi. </span>2009;<span class="ref-vol">98</span>:150–2.</span> [<a href="/pubmed/19227921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19227921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.gimmon.1982.320">Gimmon Z, Wexler MR, Rachmilewitz EA. Juvenile leg ulceration in beta-thalassemia major and intermedia. <span><span class="ref-journal">Plast Reconstr Surg. </span>1982;<span class="ref-vol">69</span>:320–5.</span> [<a href="/pubmed/7034014" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7034014</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.goodman.1968.152">Goodman SI, Solomons CC, Muschenheim F, McIntyre CA, Miles B, O'Brien D. A syndrome resembling lathyrism associated with iminodipeptiduria. <span><span class="ref-journal">Am J Med. </span>1968;<span class="ref-vol">45</span>:152–9.</span> [<a href="/pubmed/4968882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4968882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.gray.1983.143">Gray RGF, Green A, Ward AM, Anderson I, Peck DS. Biochemical and immunological studies on a family with prolidase deficiency. <span><span class="ref-journal">J Inherit Metab Dis. </span>1983;<span class="ref-vol">6</span>:143–8.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.hechtman.2001">Hechtman P. Prolidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. Chap 82. 8 ed. New York, NY: McGraw-Hill. 2001:1839-56.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.hershkovitz.2006.435">Hershkovitz T, Hassoun G, Indelman M, Shlush LI, Bergman R, Pollack S, Sprecher E. A homozygous missense mutation in PEPD encoding peptidase D causes prolidase deficiency associated with hyper-IgE syndrome. <span><span class="ref-journal">Clin Exp Dermatol. </span>2006;<span class="ref-vol">31</span>:435–40.</span> [<a href="/pubmed/16681595" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16681595</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.ikeda.1997.401">Ikeda K, Tohyama J, Tsujino S, Sato K, Oono T, Arata J, Endo F, Sakuragawa N. Amelioration of prolidase deficiency in fibroblasts using adenovirus mediated gene transfer. <span><span class="ref-journal">Jpn J Hum Genet. </span>1997;<span class="ref-vol">42</span>:401–8.</span> [<a href="/pubmed/12503186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12503186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.isemura.1979.401">Isemura M, Hanyu T, Gejyo F, Nakazawa R, Igarashi R, Matsuo S, Ikeda K, Sato Y. Prolidase deficiency with imidodipeptiduria. A familial case with and without clinical symptoms. <span><span class="ref-journal">Clin Chim Acta. </span>1979;<span class="ref-vol">93</span>:401–7.</span> [<a href="/pubmed/445856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 445856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.kavala.2006.24">Kavala M, Zindanci I, Sudogan S, Turkoglu Z, Sarigul S. Ulcus cruris associated with prolidase deficiency. <span><span class="ref-journal">Dermatol Online J. </span>2006;<span class="ref-vol">12</span>:24.</span> [<a href="/pubmed/17459310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17459310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.kelly.2010.1031">Kelly JJ, Freeman AF, Wang H, Cowen EW, Kong HH. An Amish boy with recurrent ulcerations of the lower extremities, telangiectases of the hands, and chronic lung disease. <span><span class="ref-journal">J Am Acad Dermatol. </span>2010;<span class="ref-vol">62</span>:1031–4.</span> [<a href="/pmc/articles/PMC3413893/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3413893</span></a>] [<a href="/pubmed/20466176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20466176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.kiratli.1998.49">Kiratli H, Satilmi&#x0015f; M. Prolidase deficiency associated with pathologic myopia. <span><span class="ref-journal">Ophthalmic Genet. </span>1998;<span class="ref-vol">19</span>:49–53.</span> [<a href="/pubmed/9587929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9587929</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.klar.2010.727">Klar A, Navon-Elkan P, Rubinow A, Branski D, Hurvitz H, Christensen E, Khayat M, Falik-Zaccai TC. Prolidase deficiency: it looks like systemic lupus erythematosus but it is not. <span><span class="ref-journal">Eur J Pediatr. </span>2010;<span class="ref-vol">169</span>:727–32.</span> [<a href="/pubmed/19937054" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19937054</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.knoxmacaulay.1983.411">Knox-Macaulay HH. Sickle cell disease in Sierra Leone: a clinical and haematological analysis in older children and adults. <span><span class="ref-journal">Ann Trop Med Parasitol. </span>1983;<span class="ref-vol">77</span>:411–9.</span> [<a href="/pubmed/6639186" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6639186</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.koshy.1989.1403">Koshy M, Entsuah R, Koranda A, Kraus AP, Johnson R, Bellvue R, Flournoy-Gill Z, Levy P. Leg ulcers in patients with sickle cell disease. <span><span class="ref-journal">Blood. </span>1989;<span class="ref-vol">74</span>:1403–8.</span> [<a href="/pubmed/2475188" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2475188</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.kurien.2013.674">Kurien BT, D'Sousa A, Bruner BF, Gross T, James JA, Targoff IN, Maier-Moore JS, Harley IT, Wang H, Scofield RH. Prolidase deficiency breaks tolerance to lupus-associated antigens. <span><span class="ref-journal">Int J Rheum Dis. </span>2013;<span class="ref-vol">16</span>:674–80.</span> [<a href="/pmc/articles/PMC4030668/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4030668</span></a>] [<a href="/pubmed/24330273" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24330273</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.kurien.2006.165">Kurien BT, Patel NC, Porter AC, D'Souza A, Miller D, Matsumoto H, Wang H, Scofield RH. Prolidase deficiency and the biochemical assays used in its diagnosis. <span><span class="ref-journal">Anal Biochem. </span>2006;<span class="ref-vol">349</span>:165–75.</span> [<a href="/pubmed/16298326" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16298326</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lacarbonara.2014.224">Lacarbonara M, Cazzolla AP, Lacarbonara VA, Di Venere D, Capogreco M, Marzo G. Prolidase deficiency: dento-facial aspects in a paediatric patient. <span><span class="ref-journal">Eur J Paediatr Dent. </span>2014;<span class="ref-vol">15</span>:224–8.</span> [<a href="/pubmed/25101509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25101509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lapiere.1969.353">Lapiere CM, Nusgens B. Torpid skin wounds and collagen metabolism disorder. <span><span class="ref-journal">Arch Belg Dermatol Syphiligr. </span>1969;<span class="ref-vol">25</span>:353–6.</span> [<a href="/pubmed/5401875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5401875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lemieux.1984.145">Lemieux B, Auray-Blais C, Giguere R, Shapcott D. Prolidase deficiency: detection of cases by a newborn urinary screening programme. <span><span class="ref-journal">J Inherit Metab Dis. </span>1984;<span class="ref-vol">7</span>:145–6.</span> [<a href="/pubmed/6434873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6434873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.levin.2011.316">Levin C, Koren A. Healing of refractory leg ulcer in a patient with thalassemia intermedia and hypercoagulability after 14 years of unresponsive therapy. <span><span class="ref-journal">Isr Med Assoc J. </span>2011;<span class="ref-vol">13</span>:316–8.</span> [<a href="/pubmed/21845977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21845977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lombeck.1986.571">Lombeck I, Wendel U, Versieck J, van Ballenberghe L, Bremer HJ, Duran R, Wadman S. Increased manganese content and reduced arginase activity in erythrocytes of a patient with prolidase deficiency (iminodipeptiduria). <span><span class="ref-journal">Eur J Pediatr. </span>1986;<span class="ref-vol">144</span>:571–3.</span> [<a href="/pubmed/3709569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3709569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lopes.2002.140">Lopes I, Marques L, Neves E, Silva A, Taveira M, Pena R, Vilarinho L, Martins E. Prolidase deficiency with hyperimmunoglobulin E: a case report. <span><span class="ref-journal">Pediatr Allergy Immunol. </span>2002;<span class="ref-vol">13</span>:140–2.</span> [<a href="/pubmed/12000488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12000488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.luder.2007.656">Luder AS, Mandel H, Khayat M, Gurevich I, Frankel P, Rivlin J, Falik-Zaccai TC. Chronic lung disease and cystic fibrosis phenotype in prolidase deficiency: a newly recognized association. <span><span class="ref-journal">J Pediatr. </span>2007;<span class="ref-vol">150</span>:656–8.</span> [<a href="/pubmed/17517257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17517257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lupi.2004.500">Lupi A, De Riso A, Torre SD, Rossi A, Campari E, Vilarinho L, Cetta G, Forlino A. Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. <span><span class="ref-journal">J Hum Genet. </span>2004;<span class="ref-vol">49</span>:500–6.</span> [<a href="/pubmed/15309682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15309682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lupi.2006.e58">Lupi A, Rossi A, Campari E, Pecora F, Lund AM, Elcioglu NH, Gultepe M, Di Rocco M, Cetta G, Forlino A. Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:e58.</span> [<a href="/pmc/articles/PMC2563206/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563206</span></a>] [<a href="/pubmed/17142620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17142620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.lupi.2008.739">Lupi A, Tenni R, Rossi A, Cetta G, Forlino A. Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations. <span><span class="ref-journal">Amino Acids. </span>2008;<span class="ref-vol">35</span>:739–52.</span> [<a href="/pubmed/18340504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18340504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.mandel.2000.927">Mandel H, Abeling N, Gutman A, Berant M, Scholten EG, Sheiman C, Luder A, van Gennip AH. Prolidase deficiency among an Israeli population: prenatal diagnosis in a genetic disorder with uncertain prognosis. <span><span class="ref-journal">Prenat Diagn. </span>2000;<span class="ref-vol">20</span>:927–9.</span> [<a href="/pubmed/11113899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11113899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.marotte.2010.88">Marotte H, Gineyts E, Miossec P. Prolidase deficiency: a rare aetiology of arthritis. <span><span class="ref-journal">Joint Bone Spine. </span>2010;<span class="ref-vol">77</span>:88–9.</span> [<a href="/pubmed/20031465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20031465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.martins.2000.75">Martins E, Silva A, Lopes I, Pena R, Pereira J, Vilarinho L., Society for the Study of Inborn Errors of Metabolism.  Prolidase deficiency associated to hyper IgE. <span><span class="ref-journal">J Inherit Metab Dis. </span>2000;<span class="ref-vol">23</span>:75.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.milligan.1989.405">Milligan A, Graham-Brown RA, Burns DA, Anderson I. Prolidase deficiency: a case report and literature review. <span><span class="ref-journal">Br J Dermatol. </span>1989;<span class="ref-vol">121</span>:405–9.</span> [<a href="/pubmed/2679858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2679858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.mohammed.1991.285">Mohammed SM, Suleiman SA, Addae SK, Annobil SH, Adzaku FK, Kadoummi OF, Richards JT. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease. <span><span class="ref-journal">Clin Chim Acta. </span>1991;<span class="ref-vol">203</span>:285–94.</span> [<a href="/pubmed/1777988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1777988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.monafo.2000.227">Monafo V, Marseglia GL, Maghnie M, Dyne KM, Cetta G. Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency. <span><span class="ref-journal">Pediatr Dermatol. </span>2000;<span class="ref-vol">17</span>:227–30.</span> [<a href="/pubmed/10886759" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10886759</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.moulonguet.1989.792">Moulonguet I, Bamberger N, de Larrard G, Klein F, Myara I, Blanchet-Bardon C, Markuch T, Civatte J. Leg ulcers and prolidase deficiency. <span><span class="ref-journal">Ann Dermatol Venereol. </span>1989;<span class="ref-vol">116</span>:792–4.</span> [<a href="/pubmed/2619164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2619164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.nasser.2015.169">Nasser HA, Rajab M, Tanios BY. Massive splenomegaly secondary to prolidase deficiency. <span><span class="ref-journal">Am J Med Sci. </span>2015;<span class="ref-vol">349</span>:169.</span> [<a href="/pubmed/23811574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23811574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.noda.2011.e54">Noda S, Asano Y, Masuda S, Miyagawa T, Sugita M, Yamamoto M, Kogure A, Tamaki Z, Mitsui H, Hoashi T, Sugaya M, Sato S. Bosentan: a novel therapy for leg ulcers in Werner syndrome. <span><span class="ref-journal">J Am Acad Dermatol. </span>2011;<span class="ref-vol">65</span>:e54–5.</span> [<a href="/pubmed/21763553" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21763553</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.ogata.1981.689">Ogata A, Tanaka S, Tomoda T, Murayama E, Endo F, Kikuchi I. Autosomal recessive prolidase deficiency. Three patients with recalcitrant ulcers. <span><span class="ref-journal">Arch Dermatol. </span>1981;<span class="ref-vol">117</span>:689–97.</span> [<a href="/pubmed/7316526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7316526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.pasquali_ronchetti.1991.439">Pasquali Ronchetti I, Quaglino D Jr, Dyne KM, Zanaboni G, Cetta G. Ultrastructural studies on dermis from prolidase deficient subjects. <span><span class="ref-journal">J Submicrosc Cytol Pathol. </span>1991;<span class="ref-vol">23</span>:439–45.</span> [<a href="/pubmed/1913589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1913589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.pedersen.1983.785">Pedersen PS, Christensen E, Brandt NJ. Prolidase deficiency. <span><span class="ref-journal">Acta Paediatr Scand. </span>1983;<span class="ref-vol">72</span>:785–8.</span> [<a href="/pubmed/6637477" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6637477</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.perugini.2005.181">Perugini P, Hassan K, Genta I, Modena T, Pavanetto F, Cetta G, Zanone C, Iadarola P, Asti A, Conti B. Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients. <span><span class="ref-journal">J Control Release. </span>2005;<span class="ref-vol">102</span>:181–90.</span> [<a href="/pubmed/15653144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15653144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.powell.1977.242">Powell GF, Kurosky A, Maniscalco RM. Prolidase deficiency: report of a second case with quantitation of the excessively excreted amino acids. <span><span class="ref-journal">J Pediatr. </span>1977;<span class="ref-vol">91</span>:242–6.</span> [<a href="/pubmed/874681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 874681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.powell.1974.505">Powell GF, Rasco MA, Maniscalco RM. A prolidase deficiency in man with iminopeptiduria. <span><span class="ref-journal">Metabolism. </span>1974;<span class="ref-vol">23</span>:505–13.</span> [<a href="/pubmed/4828441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4828441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.renaud.2009">Renaud J, Dagenais P. Agence d'&#x000e9;valuation des technologies et des modes d'intervention en sant&#x000e9;. La pertinence du d&#x000e9;pistage n&#x000e9;onatal urinaire des erreurs inn&#x000e9;es du m&#x000e9;tabolisme r&#x000e9;alis&#x000e9; au Qu&#x000e9;bec: rapport. Montr&#x000e9;al, Qu&#x000e9;bec: ETMIS. 2009.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.renner.2004.93">Renner ED, Puck JM, Holland SM, Schmitt M, Weiss M, Frosch M, Bergmann M, Davis J, Belohradsky BH, Grimbacher B. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity. <span><span class="ref-journal">J Pediatr. </span>2004;<span class="ref-vol">144</span>:93–9.</span> [<a href="/pubmed/14722525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14722525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.royce.2002">Royce P, Steinmann B. Prolidase deficiency. In: Royce P, Steinmann B, eds. <em>Connective Tissue and Its Heritable Disorders</em>. New York: Wiley-Liss; 2002:727-738.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.scriver.1964.357">Scriver CR. Glycyl-proline in urine of humans with bone disease. <span><span class="ref-journal">Can J Physiol Pharmacol. </span>1964;<span class="ref-vol">42</span>:357–64.</span> [<a href="/pubmed/14324167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14324167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.seakins.1963.215">Seakins JW. Peptiduria in an unusual bone disorder. Isolation of two peptides. <span><span class="ref-journal">Arch Dis Child. </span>1963;<span class="ref-vol">38</span>:215–9.</span> [<a href="/pmc/articles/PMC2019021/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2019021</span></a>] [<a href="/pubmed/13987500" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13987500</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.sekiya.1985.125">Sekiya M, Ohnishi Y, Kimura K. An autopsy case of prolidase deficiency. <span><span class="ref-journal">Virchows Arch A Pathol Anat Histopathol. </span>1985;<span class="ref-vol">406</span>:125–31.</span> [<a href="/pubmed/3922107" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3922107</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.sheffield.1977.578">Sheffield LJ, Schlesinger P, Faull K, Halpern BJ, Schier GM, Cotton RG, Hammond J, Danks DM. Iminopeptiduria, skin ulcerations, and edema in a boy with prolidase deficiency. <span><span class="ref-journal">J Pediatr. </span>1977;<span class="ref-vol">91</span>:578–83.</span> [<a href="/pubmed/908977" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 908977</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.shrinath.1997.441">Shrinath M, Walter JH, Haeney M, Couriel JM, Lewis MA, Herrick AL. Prolidase deficiency and systemic lupus erythematosus. <span><span class="ref-journal">Arch Dis Child. </span>1997;<span class="ref-vol">76</span>:441–4.</span> [<a href="/pmc/articles/PMC1717183/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1717183</span></a>] [<a href="/pubmed/9196362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9196362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.sternberg.1982.293">Sternberg N, Golan J, Sternberg I, Ben-Hur N. Werner's syndrome as a cause of chronic leg ulcers. <span><span class="ref-journal">J Dermatol Surg Oncol. </span>1982;<span class="ref-vol">8</span>:293–5.</span> [<a href="/pubmed/7076970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7076970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.stevens.1977.1558">Stevens DM, Shupack JL, Javid J, Silber R. Ulcers of the leg in thalassemia. <span><span class="ref-journal">Arch Dermatol. </span>1977;<span class="ref-vol">113</span>:1558–60.</span> [<a href="/pubmed/931395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 931395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.taher.2013">Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Leg Ulcers. In: Weatherall D, ed. <em>Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT).</em> Available <a href="/books/NBK190456/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 11-7-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.tiller.1977.20">Tiller JWG. Psychiatric problems in a boy with prolidase deficiency. <span><span class="ref-journal">Aust J Ment Retard. </span>1977;<span class="ref-vol">4</span>:20–1.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.viglio.2006.1">Viglio S, Annovazzi L, Conti B, Genta I, Perugini P, Zanone C, Casado B, Cetta G, Iadarola P. The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach. <span><span class="ref-journal">J Chromatogr B Analyt Technol Biomed Life Sci. </span>2006;<span class="ref-vol">832</span>:1–8.</span> [<a href="/pubmed/16434239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16434239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.wang.2006.580">Wang H, Kurien BT, Lundgren D, Patel NC, Kaufman KM, Miller DL, Porter AC, D'Souza A, Nye L, Tumbush J, Hupertz V, Kerr DS, Kurono S, Matsumoto H, Scofield RH. A nonsense mutation of PEPD in four Amish children with prolidase deficiency. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:580–5.</span> [<a href="/pubmed/16470701" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16470701</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.wysocki.1988.161">Wysocki SJ, Hahnel R, Mahoney T, Wilson RG, Panegyres PK. Prolidase deficiency: a patient without hydroxyproline-containing iminodipeptides in urine. <span><span class="ref-journal">J Inherit Metab Dis. </span>1988;<span class="ref-vol">11</span>:161–5.</span> [<a href="/pubmed/3139928" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3139928</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.yeong.2004.86">Yeong EK, Yang CC. Chronic leg ulcers in Werner's syndrome. <span><span class="ref-journal">Br J Plast Surg. </span>2004;<span class="ref-vol">57</span>:86–8.</span> [<a href="/pubmed/14672683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14672683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="prolidase-def.REF.zanaboni.1994.13">Zanaboni G, Dyne KM, Rossi A, Monafo V, Cetta G. Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. <span><span class="ref-journal">Haematologica. </span>1994;<span class="ref-vol">79</span>:13–8.</span> [<a href="/pubmed/15378943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15378943</span></a>]</div></li></ul></div></div><div id="prolidase-def.Chapter_Notes"><h2 id="_prolidase-def_Chapter_Notes_">Chapter Notes</h2><div id="prolidase-def.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>25 June 2015 (me) Review posted live</div></li><li class="half_rhythm"><div>20 January 2015 (cf) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK299584</span><span class="label">PMID: <a href="/pubmed/26110198" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">26110198</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/ppr-dysp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/pomc-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK299584&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK299584/?report=reader">PubReader</a></li><li><a href="/books/NBK299584/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK299584" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK299584" style="display:none" title="Cite this Page"><div class="bk_tt">Ferreira C, Wang H. Prolidase Deficiency. 2015 Jun 25. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK299584/pdf/Bookshelf_NBK299584.pdf">PDF version of this page</a> (1.3M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#prolidase-def.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#prolidase-def.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#prolidase-def.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#prolidase-def.Genetically_Related_Alleli" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#prolidase-def.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#prolidase-def.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#prolidase-def.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#prolidase-def.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#prolidase-def.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#prolidase-def.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#prolidase-def.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5184[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PEPD</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4080820" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4080820" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4080820" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4080820" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24624460" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">EPB42</i>-Related Hereditary Spherocytosis<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kalfa TA, Connor JA, Begtrup AH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21634085" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphorylase Kinase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Herbert M, Goldstein JL, Rehder C, Austin S, Kishnani PS, Bali DS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29072891" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Poikiloderma with Neutropenia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Poikiloderma with Neutropenia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang L, Clericuzio C, Larizza L. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301304" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Junctional Epidermolysis Bullosa</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Junctional Epidermolysis Bullosa<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pfendner EG, Lucky AW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301700" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carnitine Palmitoyltransferase 1A Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bennett MJ, Santani AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=26110198" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=26110198" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc946539a66ee2ba429217">Prolidase Deficiency - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Prolidase Deficiency - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:29:09-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88CB67DFC8F1E10000000002930133&amp;ncbi_session=CE88CB67DFC94641_0659SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK299584%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK299584&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK299584/&amp;ncbi_pagename=Prolidase Deficiency - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88CB67DFC94641_0659SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>